Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ET-743 in Unresectable Malignant Pleural Mesothelioma
NCT00027508Phase 2Terminated
- Sponsor
- PharmaMar
- Start
- Jul 2001
- Primary completion
- Feb 2002
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in malignant pleural mesothelioma (MPM), sponsored by PharmaMar. Started Jul 2001; status: terminated.
02
Drugs
trabectedin
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00027508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027508.